Is Eli Lilly Stock Halal?

Is Eli Lilly Stock Halal?

How much of Eli Lilly’s revenue comes from haram?

Eli Lilly develops and markets human pharmaceuticals.

Eli Lilly earns its revenue from the following segments:

  • Product Revenue:

Includes products targeting various diseases in several therapeutic areas, including Oncology, Immunology, Neuroscience, and Infectious Diseases

  • Collaboration and Other Revenue:

Includes collaboration revenue generated from Eli Lilly’s partnership with Boehringer Ingelheim

The contributions from each of Eli Lilly’s revenue segments in their 2020 annual report were as follows:

Practical Islamic Finance concludes:

None of Eli Lilly’s revenue comes from anything inherently haram.

Does Eli Lilly rely on interest to operate?

[wbcr_php_snippet id=”11367″]

What is Eli Lilly’s Environmental, Social, and Governance (ESG) impact?


Eli Lilly has reduced its Greenhouse Gas Emissions by 26% from 2012 to 2020.


Since 2009, Eli Lilly has donated more than 2.4 million vials of insulin through its Life for a Child program.

In addition, Eli Lilly has an impressive Glassdoor rating of 4.1 out of 5 from over 3,000 current and previous employees compared to a 3.3 average for all other Glassdoor rated companies.


Eli Lilly has faced criticism in the past for raising its insulin prices.

However, in June 2021, Walmart announced a fast-acting insulin competitor at a lower price.

In light of new competition from Walmart, we are less concerned with allegations Eli Lilly is not pricing its insulin fairly since not doing so would mean giving up market share to Walmart.

Practical Islamic Finance concludes:

Eli Lilly has a net positive ESG impact.

Comfort Rating

From Eli Lilly’s business, financial, and ESG reviews, Practical Islamic Finance rates Eli Lilly stock as: 

Comfortable to invest in from a halal perspective.




Environmental | 2020 ESG Report | Eli Lilly and Company 

Social | 2020 ESG Report | Eli Lilly and Company 

Eli Lilly and Company Reviews 

Eli Lilly and Company Wikipedia

Eli Lilly CEO says drugmaker will keep looking to cut insulin costs  

Subscribe to get our “Intro to Halal-Conscious Investing” and much more for FREE!

Enter your email address to subscribe:*